International Journal of Public Health

, Volume 63, Issue 5, pp 609–619 | Cite as

Attendance to cervical cancer screening among Roma and non-Roma women living in North-Western region of Romania

  • Trude AndreassenEmail author
  • Adriana Melnic
  • Rejane Figueiredo
  • Kåre Moen
  • Ofelia Şuteu
  • Florian Nicula
  • Giske Ursin
  • Elisabete Weiderpass
Original Article



Romania has Europe’s highest incidence and mortality rates of cervical cancer. Participation in the national cervical cancer-screening programme is low, especially among minority Roma women.


We conducted a cross-sectional study, using a structured questionnaire aiming to quantify reasons for screening attendance among women in North-Western region of Romania.


980 women were enrolled in this study. Data were analysed using logistic regression, estimating odds ratios (OR) and 95% confidence intervals (CI). This study revealed that Roma women (46%) attended screening less frequently that non-Roma women (63%),; however, ethnicity in itself was not associated with screening attendance. Instead we found that attendance to the cervical cancer screening programme was determined by having ever heard about a screening opportunity (OR 5.90, 95% CI 3.76−9.27) and having three or more sex partners (OR 5.99, 95% CI 1.71–21.04).


We concluded that information about the screening programme’s existence and its rationale does not reach the women targeted for screening sufficiently and argue that a process of user involvement aiming to build contact, interaction and cooperation between the programme and its potential participants is warranted.


Cervical cancer screening attendance Minority Roma women Discrimination Access to health Health insurance Odds ratio 



This study was conducted as part of CerCcRom project (Cervical Cancer among Roma and other disadvantage groups of women in Romania) with funding from the European Economic Area (EEA) Financial Mechanism 2009–2014 under Project Contract no 6SEE/30.06.2014. We thank the Romanian Cancer Society, the Oncology Institute “Prof. Dr. Ion Chiricuta” of Cluj-Napoca, Romania and the Cancer Registry of Norway, for making this study possible. We also thank all the data collectors for their contribution with and in the questionnaire meetings. Most of all we thank all the women who took part in the study.


This study was conducted as part of CerCcRom project (Cervical Cancer among Roma and other disadvantage groups of women in Romania) with funding from the European Economic Area (EEA) Financial Mechanism 2009–2014 under Project Contract no 6SEE/30.06.2014.

Compliance with ethical standards

This study was funded by the European Economic Area (EEA) Financial Mechanism 2009–2014 under Project Contract no 6SEE/30.06.2014. All authors declare that they have no conflict of interest. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

38_2018_1107_MOESM1_ESM.pdf (1.8 mb)
Supplementary material 1 (PDF 1836 kb)


  1. Andreassen T, Weiderpass E, Nicula F, Suteu O, Itu A, Bumbu M, Tincu A, Ursin G, Moen K (2017) Controversies about cervical cancer screening: a qualitative study of Roma women’s (Non) participation in cervical cancer screening in Romania. Soc Sci Med 183:48–55. CrossRefPubMedGoogle Scholar
  2. Baban Balazsi, Bradley Rusu, Szentagotai Tataru (2006) Psychosicial And Health System Dimensions Of Cervical Screening In Romania. Engenderhealth, New YorkGoogle Scholar
  3. Bayu H, Berhe Y, Mulat A, Alemu A (2016) Cervical cancer screening service uptake and associated factors among age eligible women in Mekelle Zone, Northern Ethiopia, 2015: a community based study using health belief model. PLoS One 11:E0149908. CrossRefPubMedPubMedCentralGoogle Scholar
  4. Behbakht K, Lynch A, Teal S, Degeest K, Massad S (2004) Social and cultural barriers to papanicolaou test screening in an Urban population. Obstet Gynecol 104:1355–1361. CrossRefPubMedGoogle Scholar
  5. Byrd TL, Chavez R, Wilson KM (2007) Barriers and facilitators of cervical cancer screening among hispanic women. Ethn Dis 17:129–134PubMedGoogle Scholar
  6. Chorley AJ, Hirst Y, Vrinten C, Von Wagner C, Wardle J, Waller J (2017) Public understanding of the purpose of cancer screening: a population-based survey. J Med Screen. PubMedPubMedCentralCrossRefGoogle Scholar
  7. Cummings P (2013) Missing data and multiple imputation. JAMA, 167, pp 656–661Google Scholar
  8. De Freitas C, Martin G (2015) Inclusive public participation in health: policy practice and theoretical contributions to promote the involvement of marginalised groups in healthcare. Soc Sci Med 135:31–39. CrossRefPubMedGoogle Scholar
  9. Eardley A, Elkind AK, Spencer B, Hobbs P, Pendleton LL, Haran D (1985) Attendance For Cervical Screening—Whose Problem? Soc Sci Med 20:955–962CrossRefPubMedGoogle Scholar
  10. Ekechi C, Olaitan A, Ellis R, Koris J, Amajuoyi A, Marlow La (2014) Knowledge of cervical cancer and attendance at cervical cancer screening: a survey of black women. In: London BMC Public Health 14:1096
  11. Engebrigtsen A (2007) Exploring gypsiness: power, exchange and interdependence in a Transylvanian Village. Oxford, United KingdomGoogle Scholar
  12. Escriba-Aguir V, Rodriguez-Gomez M, Ruiz-Perez I (2016) Effectiveness of patient-targeted interventions to promote cancer screening among ethnic minorities: a systematic review. Cancer Epidemiol 44:22–39. CrossRefPubMedGoogle Scholar
  13. European Commission (2014) Report on the health status of the Roma population in the Eu and monitoring data collection in the area of Roma health in the member statesGoogle Scholar
  14. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan. Int J Cancer 136:E359–386. CrossRefPubMedGoogle Scholar
  15. Gimeno Garcia AZ (2012) Factors influencing colorectal cancer screening participation. Gastroenterol Res Prac 2012:1–8. CrossRefGoogle Scholar
  16. Government Of Romania (2016–2017) Hotarare De Guvern. Hg Nr. 161/2016 Pentru Aprobarea Pachetelor De Servicii Şi A Contractului-Cadru 2016-2017 [Decision 161 Of 16.03.2016 Concerning The Endorsement Of The Combined Services And The Framework Agreement That Regulates The Conditions Of The Granting Of Medical Assistance, Medicine And Medical Devices Under The Social Health Insurance System 2016–2017]Google Scholar
  17. Hajioff S, Mckee M (2000) The health of the Roma people: a review of the published literature. J Epidemiol Community Health 54:864–869CrossRefPubMedPubMedCentralGoogle Scholar
  18. Hickey G, Kipping C (1998) Exploring the concept of user involvement in mental health through a participation continuum. J Clin Nurs 7:83–88CrossRefPubMedGoogle Scholar
  19. Hosmer L (2000) Applied Logistic Regression. Wiley, New YorkCrossRefGoogle Scholar
  20. Iocn (2017) North-Western Cancer Registry. Cancer In North-Western Region Of Romania. Www.Iocn.Ro. Accessed 08.08.2017 2017
  21. Jepson RG, Hewison J, Thompson A, Weller D (2007) Patient perspectives on information and choice in cancer screening: a qualitative study in the UK. Soc Sci Med 65:890–899. CrossRefPubMedGoogle Scholar
  22. Kuhlbrandt C, Footman K, Rechel B, Mckee M (2014) An examination of Roma health insurance status in central and Eastern Europe. Eur J Pub Health 24:707–712. CrossRefGoogle Scholar
  23. Li KK, Abelson J, Giacomini M, Contandriopoulos D (2015a) Conceptualizing the use of public involvement in health policy decision-making. Soc Sci Med 138:14–21. CrossRefPubMedGoogle Scholar
  24. Li P, Stuart E, Allison D (2015b) Multiple imputation: a flexible tool for handling missing data. JAMA 10(318):314. CrossRefGoogle Scholar
  25. Lim AW, Sasieni P (2015) Consultation rates in cervical screening non-attenders: opportunities to increase screening uptake in Gp primary care. J Med Screen 22:93–99. CrossRefPubMedPubMedCentralGoogle Scholar
  26. Marlow LA, Waller J, Wardle J (2015) J barriers to cervical cancer screening among ethnic minority women: a qualitative study. J Fam Plann Reprod Health Care 41:248–254. CrossRefPubMedPubMedCentralGoogle Scholar
  27. Masseria C, Mladovsky P, Hernandez-Quevedo C (2010) The socio-economic determinants of the health status of roma in comparison with non-roma in bulgaria. Hung Roman Eur J Public Health 20:549–554. CrossRefGoogle Scholar
  28. Ministry Of Health (2015) Ministerul Sănătăţii. Normă Tehnică Din 31/03/2015. Versiune Actualizata La Data De 08/03/2016. Normele Tehnice De Realizare A Programelor Naţionale De Publică Pentru Anii 2015 Şi 2016, Din 31.03.2015. [Technical Standard Of 03/13/2015. Version Updated On 03/08/2016. Rules For Carrying Out The National Public Health Programs For 2015 And 2016, 31.03.2015]Google Scholar
  29. Moser K, Patnick J, Beral V (2009) Inequalities in reported use of breast and cervical screening In Great Britain: analysis of cross sectional survey data. BMJ 338:B2025. CrossRefPubMedPubMedCentralGoogle Scholar
  30. Mutyaba Faxelid, Mirembe Weiderpass (2007) Influences on uptake of reproductive health services in Nsangi Community Of Uganda and their implications for cercvical cancer screening biomed central. Reprod Health 4:1–9CrossRefGoogle Scholar
  31. National Instistue Of Statistics (2011) Recensamantul Populatiei Si Locuintelor 2011 [The Reference For Population And Household Census From 2011] Institutul National De Statistice [National Instistue Of Statistics]. Accessed 11.08.2017Google Scholar
  32. Ogunwale AN, Sangi-Haghpeykar H, Montealegre J (2016) Non-utilization of the pap test among women with frequent health system contact. J Immigr Minor Health 18:1404–1412CrossRefPubMedGoogle Scholar
  33. Rutter D, Manley C, Weaver T, Mj Crawford, Fulop N (2004) Patients or partners? Case studies of user involvement in the planning and delivery of adult mental health services in London. Soc Sci Med 58:1973–1984. CrossRefPubMedGoogle Scholar
  34. Smith AM, Heywood W, Ryall R, Shelley JM, Pitts MK, Richters J, Simpson JM, Patrick K (2011) Association between sexual behavior and cervical cancer screening. J Women’s Health 20:1091–1096. CrossRefGoogle Scholar
  35. Socolov D, Socolov R, Lupascu IA, Rugina V, Gabia O, Garauleanu DM, Carauleanu A (2016) Immunohistochemistry in endometrial hyperplasia and endometrial adenocarcinoma. Rev Med Chir Soc Med Nat Iasi 120:355–362PubMedGoogle Scholar
  36. The World Bank Group (2014) Achiving Roma inclusion In Romania-what does it take?Google Scholar
  37. Todorova I, Baban A, Alexandrova-Karamanova A, Bradley J (2009) Inequalities in cervical cancer screening in Eastern Europe: perspectives from Bulgaria And Romania. Int J Public Health 54:222–232. CrossRefPubMedGoogle Scholar
  38. Vladescu C, Sg Scintee, Olsavszky V, Hernandez-Quevedo C, Sagan A (2016) Romania: health system review. Health Syst Trans 18:1–170Google Scholar
  39. Wamsiedel M, Vincze E, Ionescu I (2012) Roma health. Perspective of the actors involved in the health system—doctors, health mediators and patients. Romani Criss—Roma Center For Social Intervention and studiesGoogle Scholar

Copyright information

© Swiss School of Public Health (SSPH+) 2018

Authors and Affiliations

  1. 1.Cancer Registry of Norway, Institute of Population-Based Cancer ResearchOsloNorway
  2. 2.Institute of Basic Medical SciencesUniversity of OsloOsloNorway
  3. 3.The Romanian Cancer SocietyCluj-NapocaRomania
  4. 4.Folkhälsan Research Center, Genetic Epidemiology GroupHelsinkiFinland
  5. 5.Institute of Health and SocietyUniversity of OsloOsloNorway
  6. 6.University of Medicine and Pharmacy, “Iuliu Haţieganu”Cluj-NapocaRomania
  7. 7.Institute of Oncology “Prof. Dr. Ion Chiricuţă” Cluj-Napoca (IOCN)Cluj-NapocaRomania
  8. 8.Department of Preventive MedicineUniversity of Southern CaliforniaLos AngelesUSA
  9. 9.Department of Community Medicine, Faculty of Health SciencesUniversity of Tromsø, The Arctic University of NorwayTromsøNorway
  10. 10.Department of Medical Epidemiology and BiostatisticsKarolinska InstitutetStockholmSweden

Personalised recommendations